2 completed, 1 active not recruiting. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Pulmonary Sarcoidosis: new trials by email Literature Review of Pulmonary Sarcoidosis trials Research Report on Pulmonary Sarcoidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations XTMAB-16 or Placebo - Pulmonary Sarcoidosis | Phase 1 / Phase 2 | Active not recruiting | Xentria, Inc. | 32 | 2023-11-10 | 2026-10-02 |
| Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis Efzofitimod 1.0 mg/kg or Placebo, Efzofitimod 3.0 mg/kg or Placebo, Efzofitimod 5.0 mg/kg or Placebo - Pulmonary Sarcoidosis | Phase 1 / Phase 2 | Completed | aTyr Pharma, Inc. | 37 | 2019-01-29 | 2023-07-18 |
| Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis levaquin; ethambutol; rifampin and azithromycin. - Pulmonary Sarcoidosis, Lung Function | Phase 1 | Completed | Vanderbilt University | 15 | 2010-07-01 | 2012-10-31 |
Sarcoidosis, Pulmonary (3) · Sarcoidosis (2) · Granuloma (1) · Inflammation (1) · Lung Diseases, Interstitial (1) · Lymphoproliferative Disorders (1) · Mycobacterium Infections (1)
Hemic and Lymphatic Diseases (3) · Hypersensitivity (3) · Hypersensitivity, Delayed (3) · Immune System Diseases (3) · Lung Diseases (3) · Lymphatic Diseases (3) · Respiratory Tract Diseases (3) · Lung Diseases, Interstitial (2) · Lymphoproliferative Disorders (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Immunoproliferative Disorders (1) · Infections (1)
Azithromycin (1) · Ethambutol (1) · Levofloxacin (1) · Rifampin (1)
Vanderbilt University (1) · Xentria, Inc. (1) · aTyr Pharma, Inc. (1)
United States (3) · Czechia (1) · Denmark (1) · Poland (1) · Spain (1) · United Kingdom (1)
Gennyne Walker (1) · Wonder P Drake, MD (1)